Approval · Notice of Compliance 16728 · 2015
PUREGON: Notice of Compliance 16728
Issued March 30, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16728
- Date
- March 30, 2015
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph
- Therapeutic class
- Human gonadotropin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PUREGON | Not yet assigned | — |
Medicinal ingredients
- FOLLITROPIN BETA 350 UNIT per ML
- FOLLITROPIN BETA 650 UNIT per ML
- FOLLITROPIN BETA 975 UNIT per ML
- FOLLITROPIN BETA 50 UNIT per 0.5ML
- FOLLITROPIN BETA 100 UNIT per 0.5ML